Overview

Ulinastatin in Severe Acute Pancreatitis

Status:
Suspended
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of ulinastatin in the treatment and prevention of organ failure in severe acute pancreatitis.
Phase:
Phase 4
Details
Lead Sponsor:
Techpool Bio-Pharma Co., Ltd.
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University
Peking Union Medical College Hospital
The First Affiliated Hospital with Nanjing Medical University
The first clinical college of harbin medical university
West China Hospital
Wuhan Union Hospital, China
Treatments:
Pharmaceutical Solutions
Trypsin Inhibitors
Urinastatin